MEDIVATION, INC. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows, 6 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-09-28: Reporting owner Yang Tseli Lily; Form 4; Security Performance-Based Restricted Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2016-09-28: Reporting owner Powell Andrew Kenneth William; Form 4; Security Performance-Based Restricted Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2016-09-28: Reporting owner Jarrett Jennifer; Form 4; Security Performance-Based Restricted Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2016-09-28: Reporting owner Hung David; Form 4; Security Performance-Based Restricted Stock Units; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-09-28 | Yang Tseli Lily Officer (VP, Finance and Accounting) | 4 | Performance-Based Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,750 0 owned after | no price filed | 2016-09-30 | |
| 2016-09-28 | Powell Andrew Kenneth William Officer (SVP, General Counsel & Crp Sec) | 4 | Performance-Based Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,474 0 owned after | no price filed | 2016-09-30 | |
| 2016-09-28 | Jarrett Jennifer Officer (Chief Financial Officer) | 4 | Performance-Based Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −37,463 0 owned after | no price filed | 2016-09-30 | |
| 2016-09-28 | Hung David Director, Officer (President and CEO) | 4 | Performance-Based Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −77,337 0 owned after | no price filed | 2016-09-30 | |
| 2016-09-28 | Hirmand Mohammad Officer (Interim Chief Medical Officer) | 4 | Performance-Based Restricted Stock Units Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,474 0 owned after | no price filed | 2016-09-30 | |
| 2013-06-13 | Kelsey Stephen Michael Officer (SVP of New Projects) | 4 | Restricted Stock Units Non-derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,500 17,500 owned after | $0.00 | 2013-06-18 |